World's Best Scientists 2026 revealed!
Richard N. Greenberg

Richard N. Greenberg

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
16472
World Ranking
13599
National Ranking
5768

Overview

Richard N. Greenberg is affiliated with the University of Kentucky in the United States and has contributed to the field of medicine, with a focus on infectious diseases, epidemiology, virology, molecular biology, and health. Their research topics cover a range of subjects related to infectious diseases and public health, including SARS-CoV-2 and COVID-19 research, poxvirus outbreaks, bacterial research on Bacillus and Francisella, vaccine coverage and hesitancy, clinical research on COVID-19, pneumonia, respiratory infections, and sepsis diagnosis and treatment.

Among the recent papers authored or co-authored by this researcher are:

  • Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine, 2024, Human Vaccines & Immunotherapeutics
  • Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia, 2022, Intensive Care Medicine
  • Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study, 2021, Mycoses
  • Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021, 2023, Open Forum Infectious Diseases
  • Erratum to: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis [J Hepatol (2019); 70 (5): 930-940], 2021, Journal of Hepatology

Frequent co-authors in their research include:

  • Thomas J. Martin
  • Nitin Seam
  • Antonio Anzueto
  • Peruvemba Sriram
  • Charlie Lan

Their work has been published in several distinct scientific venues, indicating a broad interdisciplinary reach in the medical and health sciences fields. These publication venues include:

  • Intensive Care Medicine
  • Human Vaccines & Immunotherapeutics
  • Mycoses
  • Open Forum Infectious Diseases
  • Journal of Hepatology

Richard N. Greenberg's research addresses critical aspects of infectious disease management, vaccine efficacy, and treatment protocols. The body of work demonstrates involvement in both clinical research studies and broader epidemiological investigations. This includes notable research on treatments for severe pneumonia, vaccine development for viral pathogens, as well as antifungal therapies for invasive infections.

Best Publications

  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  • Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

    Thomas J. Walsh;Robert W. Finberg;Carola Arndt;John Hiemenz

  • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

    Thomas J. Walsh;Peter Pappas;Drew J. Winston;Hillard M. Lazarus

  • A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease

    Lynne V. McFarland;Christina M. Surawicz;Richard N. Greenberg;Robert Fekety

  • Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections

    John R. Perfect;Kieren A. Marr;Thomas J. Walsh;Richard N. Greenberg

  • The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High-Dose Vancomycin Combined with Saccharomyces boulardii

    Christina M. Surawicz;Lynne V. McFarland;Richard N. Greenberg;Moshe Rubin

  • Posaconazole as salvage therapy for zygomycosis

    R. N. Greenberg;R. N. Greenberg;K. Mullane;J. A H Van Burik;I. Raad

  • Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.

    Robert Fekety;Lynne V. McFarland;Christina M. Surawicz;Richard N. Greenberg

  • Recurrent Clostridium difficile disease : Epidemiology and clinical characteristics

    Lynne V. McFarland;Christina M. Surawicz;Moshe Rubin;Robert Fekety

  • Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.

    Gary R. Hudes;Faith Nathan;Christina Khater;Naomi Haas

  • Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

    G R Hudes;R Greenberg;R L Krigel;S Fox

  • Zygomycosis (mucormycosis): emerging clinical importance and new treatments

    Richard N Greenberg;Lauren J Scott;Heather H Vaughn;Julie A Ribes

  • Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

    Issam I. Raad;John R. Graybill;Ana Beatriz Bustamante;Oliver A. Cornely

  • Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

    Lisa A. Jackson;Alejandra Gurtman;Kathryn Rice;Karlis Pauksens

  • HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages

    James Dressman;Jeanie Kincer;Sergey V. Matveev;Ling Guo

  • Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

    Marc Gurwith;Michael Lock;Eve M Taylor;Glenn Ishioka

  • Pharmacoeconomic Analysis of Liposomal Amphotericin B Versus Conventional Amphotericin B in the Empirical Treatment of Persistently Febrile Neutropenic Patients

    Pablo J. Cagnoni;Thomas J. Walsh;Mary M. Prendergast;David Bodensteiner

  • Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age

    Richard N. Greenberg;Alejandra Gurtman;Robert W. Frenck;Cynthia Strout

  • Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone.

    Richard N. Greenberg;Michael Hill;Jessica Crytzer;William J. Krause

  • IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.

    Jeffrey S Kennedy;Richard N Greenberg

Frequent Co-Authors

Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
David D. Y. Chen
David D. Y. Chen University of British Columbia
Avindra Nath
Avindra Nath National Institutes of Health
Michael S. Simberkoff
Michael S. Simberkoff New York University
Myron J. Levin
Myron J. Levin University of Colorado Anschutz Medical Campus
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
Michael N. Oxman
Michael N. Oxman University of California, San Diego
Robert D. Arbeit
Robert D. Arbeit Tufts University
Kenneth E. Schmader
Kenneth E. Schmader Duke University
Marie R. Griffin
Marie R. Griffin Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry unlocks a wide range of online degree options and career pathways in the health and science sectors. If you’re interested in leadership and administration within healthcare, doctoral programs for healthcare administration can prepare you for senior roles in hospitals, health systems, or public policy.

For those drawn to pharmaceuticals and medication management, online pharmacy schools provide advanced training and open doors to careers as pharmacists, clinical researchers, or pharmaceutical consultants.

Interested in health, fitness, or wellness? An online exercise science degree combines biology with applied science, leading to professions in athletic training, wellness coaching, or rehabilitation.

Additionally, online kinesiology degrees focus on human movement. These programs are great for those aiming to work in physical therapy, sports performance, or occupational health.

Together, these related online degrees offer flexible learning options and a variety of rewarding career pathways—all rooted in a strong foundation in Biology and Biochemistry.

Best Scientists Citing Richard N. Greenberg

Trending Scientists